Zimmer Biomet Holdings Stock Net Income

ZBH Stock  USD 119.43  0.10  0.08%   
Zimmer Biomet Holdings fundamentals help investors to digest information that contributes to Zimmer Biomet's financial success or failures. It also enables traders to predict the movement of Zimmer Stock. The fundamental analysis module provides a way to measure Zimmer Biomet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zimmer Biomet stock.
Last ReportedProjected for Next Year
Net IncomeB585 M
Net Income Applicable To Common Shares266.1 M252.8 M
Net Income From Continuing Ops475.2 M445.5 M
Net Income Per Share 4.88  5.13 
Net Income Per E B T 0.96  0.81 
The Zimmer Biomet's current Net Income Per Share is estimated to increase to 5.13, while Net Income is projected to decrease to under 585 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Zimmer Biomet Holdings Company Net Income Analysis

Zimmer Biomet's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Zimmer Biomet Net Income

    
  1.02 B  
Most of Zimmer Biomet's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zimmer Biomet Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Zimmer Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Zimmer Biomet is extremely important. It helps to project a fair market value of Zimmer Stock properly, considering its historical fundamentals such as Net Income. Since Zimmer Biomet's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zimmer Biomet's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zimmer Biomet's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Zimmer Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

(181.45 Million)

As of now, Zimmer Biomet's Accumulated Other Comprehensive Income is decreasing as compared to previous years.
Based on the recorded statements, Zimmer Biomet Holdings reported net income of 1.02 B. This is 200.04% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 79.34% lower than that of the firm.

Zimmer Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zimmer Biomet's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zimmer Biomet could also be used in its relative valuation, which is a method of valuing Zimmer Biomet by comparing valuation metrics of similar companies.
Zimmer Biomet is currently under evaluation in net income category among related companies.

Zimmer Biomet ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zimmer Biomet's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zimmer Biomet's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Zimmer Biomet Institutional Holders

Institutional Holdings refers to the ownership stake in Zimmer Biomet that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Zimmer Biomet's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Zimmer Biomet's value.
Shares
Victory Capital Management Inc.2023-12-31
3.2 M
Van Eck Associates Corporation2023-12-31
2.8 M
Morgan Stanley - Brokerage Accounts2023-12-31
2.8 M
Allspring Global Investments Holdings, Llc2023-12-31
2.8 M
Boston Partners Global Investors, Inc2023-12-31
2.6 M
Northern Trust Corp2023-12-31
2.5 M
Norges Bank2023-12-31
2.2 M
Neuberger Berman Group Llc2023-12-31
2.2 M
Legal & General Group Plc2023-12-31
2.1 M
Vanguard Group Inc2023-12-31
23.9 M
Blackrock Inc2023-12-31
18.7 M

Zimmer Fundamentals

About Zimmer Biomet Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Zimmer Biomet Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zimmer Biomet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zimmer Biomet Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out Zimmer Biomet Piotroski F Score and Zimmer Biomet Altman Z Score analysis.
Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.16)
Dividend Share
0.96
Earnings Share
4.88
Revenue Per Share
35.43
Quarterly Revenue Growth
0.063
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.